Literature DB >> 28390191

Molecular Imaging and Oral Cancer Diagnosis and Therapy.

Maryam Keshavarzi1, Mansoreh Darijani2, Fatemeh Momeni3, Pouya Moradi4, Hamed Ebrahimnejad2, Aria Masoudifar5, Hamed Mirzaei6.   

Abstract

Oral cancer is known as one of relatively common type of cancer worldwide. Despite the easy access of the oral cavity to examination, oral tumors are diagnosed in more advanced stages of the disease. Imaging techniques have been recently emerged as non-invasive approaches to detect molecular and cellular changes in living cells and organisms. These techniques such as computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET) could help physicians to screen patients with oral tumors particularly oral squamous cell carcinoma (OSCC) in early stage of the disease. In this review, we discuss that early detection and diagnosis of oral tumors through using more robust and precise imaging techniques and a variety of cellular/molecular biomarkers not only could lead to more effective and less aggressive form of treatment for the disease but also could improve survival rates and lower treatment costs. J. Cell. Biochem. 118: 3055-3060, 2017.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  DIAGNOSIS; IMAGING TECHNIQUE; ORAL CANCER; THERAPY

Mesh:

Substances:

Year:  2017        PMID: 28390191     DOI: 10.1002/jcb.26042

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  17 in total

1.  Knockdown of lncRNA LEF1-AS1 inhibited the progression of oral squamous cell carcinoma (OSCC) via Hippo signaling pathway.

Authors:  Chanqiong Zhang; Chunchun Bao; Xiuxing Zhang; Xinshi Lin; Dan Pan; Yangzong Chen
Journal:  Cancer Biol Ther       Date:  2019-04-14       Impact factor: 4.742

2.  circ_0004872 inhibits proliferation, invasion, and glycolysis of oral squamous cell carcinoma by sponged miR-424-5p.

Authors:  Yinhua Dai; Yalin Zhu; Houyi Xu
Journal:  J Clin Lab Anal       Date:  2022-05-16       Impact factor: 3.124

3.  [Expression and functions of long non-coding RNA actin filament-associated protein 1-antisense RNA1 in oral squamous cell carcinoma].

Authors:  Yu-Dong Geng; Shu-Bin Wang; Tai-Qing Lu; Wei Teng
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2019-12-01

Review 4.  Small extracellular vesicles in cancer.

Authors:  Komal Abhange; Amy Makler; Yi Wen; Natasha Ramnauth; Wenjun Mao; Waseem Asghar; Yuan Wan
Journal:  Bioact Mater       Date:  2021-04-07

5.  Magnetic Gold Nanoparticle-Labeled Heparanase Monoclonal Antibody and its Subsequent Application for Tumor Magnetic Resonance Imaging.

Authors:  Ning Li; Meng-Meng Jie; Min Yang; Li Tang; Si-Yuan Chen; Xue-Mei Sun; Bo Tang; Shi-Ming Yang
Journal:  Nanoscale Res Lett       Date:  2018-04-18       Impact factor: 4.703

6.  LncRNA LUADT1 Promotes Oral Squamous Cell Carcinoma Cell Proliferation by Regulating miR-34a/GAS1 Axis.

Authors:  Lirong Gao; Siming Wang; Junru Meng; Yugang Sun
Journal:  Cancer Manag Res       Date:  2020-05-13       Impact factor: 3.989

7.  lncRNA MALAT1 potentiates the progression of tongue squamous cell carcinoma through regulating miR-140-5p-PAK1 pathway.

Authors:  Minhui Zhu; Caiyun Zhang; Donghui Chen; Shicai Chen; Hongliang Zheng
Journal:  Onco Targets Ther       Date:  2019-02-19       Impact factor: 4.147

8.  Identification of AUNIP as a candidate diagnostic and prognostic biomarker for oral squamous cell carcinoma.

Authors:  Zongcheng Yang; Xiuming Liang; Yue Fu; Yingjiao Liu; Lixin Zheng; Fen Liu; Tongyu Li; Xiaolin Yin; Xu Qiao; Xin Xu
Journal:  EBioMedicine       Date:  2019-08-10       Impact factor: 8.143

Review 9.  Nanotechnology: a promising method for oral cancer detection and diagnosis.

Authors:  Xiao-Jie Chen; Xue-Qiong Zhang; Qi Liu; Jing Zhang; Gang Zhou
Journal:  J Nanobiotechnology       Date:  2018-06-11       Impact factor: 10.435

Review 10.  Chronic obstructive pulmonary disease: MicroRNAs and exosomes as new diagnostic and therapeutic biomarkers.

Authors:  Jafar Salimian; Hamed Mirzaei; Abdullah Moridikia; Asghar Beigi Harchegani; Amirhossein Sahebkar; Hossein Salehi
Journal:  J Res Med Sci       Date:  2018-03-27       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.